TP53 and neoplasm: Indeed, FACS analysis of tumor cells revealed that the percentage of FZD7+ cells increased after treatment with cisplatin alone in both p53/BRCA1-deficient and C3(1)-Tag models, and co-administration of TcdBFBD greatly reduced FZD7+ cells (Fig 6C).